Welcome to the e-CCO Library!

DOP33 Stratification of patients for treatment with adalimumab by a combination of immune-profiling and in vivo efficacy studies in a novel mouse model of ulcerative colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

R. Gropp1, H. Jodeleit1, J. Caesar1, C. Villarroel Aguilera1, S. Sterz2, L. Holdt2, F. Beigel3, S. Breiteneicher3, J. Stallhofer3, M. Siebeck1

Created: Thursday, 30 January 2020, 10:12 AM
DOP33: Distinct perturbances in metabolic pathways associate with disease progression in patients with Inflammatory Bowel Disease
Year: 2024
Source: ECCO'24 Stockholm
Authors: Bourgonje, Arno R.
Created: Tuesday, 30 April 2024, 5:03 PM
DOP33: Long-term clinical efficacy of ustekinumab in refractory Crohn’s disease : a multi-centre Belgian cohort study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

C. Liefferinckx*1, B. Verstockt2, A. Gils3, M. Noman2, C. Van Kemseke4, E. Macken5, M. De Vos6, W. Van Moerkercke7, J-F. Rahier8, P. Bossuyt9, J. Dutré10, E. Humblet11, D. Staessen12, H. Peters13, P. Van Hootegem14, E. Louis4, D. Franchimont1, F. Baert15, S. Vermeire2

Created: Friday, 22 February 2019, 9:41 AM
DOP33: Long-term clinical efficacy of ustekinumab in refractory Crohn’s disease : a multi-centre Belgian cohort study
Year: 2019
Source: ECCO'19 Copenhagen
Authors: Claire Liefferinckx
Created: Tuesday, 28 May 2019, 3:32 PM
Ustekinumab, Real world data
Files: 1
DOP33: Predictors of ileo-rectal anastomosis, permanent ileostomy and recurrence of disease after total colectomy for Crohn’s Colitis: Results over 20 years
Year: 2021
Source: ECCO'21 Virtual
Authors: Rottoli, M.(1);Melina, M.(1);Tanzanu, M.(1);Romano, A.(1);Belvedere, A.(1);Parlanti, D.(1);Pezzuto, A.P.(1);Salice, M.(2);Rizzello, F.(2);Gionchetti, P.(2);Poggioli, G.(1)
Created: Wednesday, 2 June 2021, 4:12 PM
DOP33: Role of adherent and invasive E. coli in Crohn’s Disease: Lessons from the postoperative recurrence model
Year: 2022
Source: ECCO'22
Authors: Buisson, A.(1);Sokol, H.(2);Hammoudi, N.(3);Nancey, S.(4);Treton, X.(5);Nachury, M.(6);Fumery, M.(7);Hébuterne, X.(8);Rodrigues, M.(9);Hugot, J.P.(10);Boschetti, G.(4);Stefanescu, C.(5);Wils , P.(6);Seksik, P.(2);Le Bourhis, L.(3);Bezault, M.(11);Sauvanet, P.(9);Pereira, B.(12);Allez, M.(3);Barnich, N.(9);
Created: Friday, 11 February 2022, 3:52 PM
DOP33: Single-cell analysis identifies pathological fibroblasts as a new therapeutic target to prevent intestinal fibrosis in Crohn's disease.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Ke, B.J.(1);Abdurahiman, S.(1);Biscu, F.(1);Verstockt, S.(1);Verstockt, B.(2);de Hertogh, G.(3);Vermeire, S.(2);Matteoli, G.(1)*;
Created: Friday, 14 July 2023, 10:43 AM
DOP33: Single-cell analysis identifies pathological fibroblasts as a new therapeutic target to prevent intestinal fibrosis in Crohn’s disease.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Gianluca Matteoli
Created: Friday, 14 July 2023, 2:22 PM
DOP34 Transplantation of human intestine into the mouse: A novel platform for study of inflammatory enterocutaneous fistulas
Year: 2020
Source:

ECCO'20 Vienna

Authors:

R.S. Bruckner1, E. Nissim-Eliraz2, N. Marsiano2, E. Nir2, H. Shemesh2, M. Leutenegger1, C. Gottier1, S. Lang1, M.R. Spalinger1, S. Leibl3, G. Rogler1,4, S. Yagel5, M. Scharl1,4, N.Y. Shpigel2

Created: Thursday, 30 January 2020, 10:12 AM
DOP34: Comparison of the risk of clinical recurrence after ileocolonic resection for Crohn's Disease for modified Rutgeerts' score i2a and i2b categories: Individual patient data meta-analysis
Year: 2022
Source: ECCO'22
Authors: Riviere, P.(1);Pekow, J.(2);Hammoudi, N.(3);Wils, P.(4);De Cruz, P.(5);Wang, C.(6);Mañosa, M.(7);Ollech, J.(2);Allez, M.(3);Nachury, M.(4);Kamm, M.(5);Maya, A.(2);Ferrante, M.(8);Buisson, A.(9);Singh, S.(10);Laharie, D.(1);Momar, D.(11);Fumery, M.(12);
Created: Friday, 11 February 2022, 3:52 PM
DOP34: Deciphering immune-epithelial interactions in health and in Inflammatory Bowel Disease
Year: 2024
Source: ECCO'24 Stockholm
Authors: Neves, Joana F
Created: Tuesday, 30 April 2024, 5:03 PM
DOP34: Disease activity patterns during the first 5 years after diagnosis in children with ulcerative colitis: a population-based study
Year: 2019
Source: ECCO'19 Copenhagen
Authors: Marina Aloi
Created: Tuesday, 28 May 2019, 3:32 PM
Montreal Classification, Paediatric
Files: 1
DOP34: Disease activity patterns during the first 5 years after diagnosis in children with ulcerative colitis: a population-based study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Aloi*1, M. Bramuzzo2, L. Norsa3, S. Arrigo4, M. Distante5, E. Miele6, A. Agrusti2, C. Romano7, C. Giobbi5, R. Panceri8, L. D’Antiga3, S. Cucchiara5, P. Alvisi9, SIGENP IBD Working Group1

Created: Friday, 22 February 2019, 9:41 AM
DOP34: Human MD2 deficiency - an inborn error of immunity predisposing to early onset Inflammatory Bowel Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Yue Li
Created: Friday, 14 July 2023, 2:22 PM
DOP34: Human MD2 deficiency - an inborn error of immunity predisposing to early onset Inflammatory Bowel Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Li, Y.(1)*;Yu, Z.(1);Schenk, M.(1);Lagovsky, I.(2);Illig, D.(1);Walz, C.(3);Rohlfs, M.(1);Conca, R.(1);Muise, A.(4);Snapper, S.(5);Uhlig, H.(6);Garty, B.(7);Klein, C.(1);Kotlarz, D.(1);
Created: Friday, 14 July 2023, 10:43 AM
DOP34: Long-term outcome of Acute Severe Ulcerative Colitis responsive to intravenous steroid: A multicenter study of the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD)
Year: 2021
Source: ECCO'21 Virtual
Authors: Festa, S.(1);Scribano, M.L.(2);Aratari, A.(1);Bezzio, C.(3);Principi, M.(4);Pugliese, D.(5);Ribaldone, D.G.(6);Furfaro, F.(7);Mocci, G.(8);Spagnuolo, R.(9);Vernia, P.(10);Costa, F.(11);Cosintino , R.(2);De Biasio, F.(1);Saibeni, S.(3);Armuzzi, A.(5);Papi, C.(1)
Created: Wednesday, 2 June 2021, 4:12 PM
DOP34: Transplantation of human intestine into the mouse: A novel platform for study of inflammatory enterocutaneous fistulas
Year: 2020
Source: ECCO'20 Vienna
Authors: Michael Scharl
Created: Tuesday, 23 June 2020, 4:58 PM
Files: 1
DOP35 Monitoring of mucosal T cells subsets under biotherapies in IBD: responders exhibit a phenotype similar to healthy controls
Year: 2020
Source:

ECCO'20 Vienna

Authors:

N. Hammoudi1, K. Perez1, D. Hassid1, M.L. Tran Minh1, J.M. Gornet1, C. Baudry1, N. Lourenco1, B. Gergaud2, V. Chardiny2, J. Bonnet1, L. Le Bourhis2, M. Allez1

Created: Thursday, 30 January 2020, 10:12 AM
DOP35: Ambulatory care management of 70 patients with Acute Severe Ulcerative Colitis in comparison to 700 inpatients: Insights from a multicentre UK cohort study
Year: 2021
Source: ECCO'21 Virtual
Authors: Patel, K.V.(1);Segal, J.(2);Sebastian, S.(3,4);Subramanian, S.(5,6);Conley, T.(5);Gonzalez, H.(3,4);Kent, A.(7);Saifuddin, A.(7);Hicks, L.(2);Mehta, S.(8);Bhala, N.(9,10);Brookes, M.(11,12);Lamb, C.(13,14);Kennedy, N.(15,16);Walker, G.(17)
Created: Wednesday, 2 June 2021, 4:12 PM